These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
133 related articles for article (PubMed ID: 16157230)
1. Adverse events among patients in a behavioral treatment trial for heroin and cocaine dependence: effects of age, race, and gender. Schroeder JR; Schmittner JP; Epstein DH; Preston KL Drug Alcohol Depend; 2005 Oct; 80(1):45-51. PubMed ID: 16157230 [TBL] [Abstract][Full Text] [Related]
2. What factors are associated with high-frequency drug treatment use among a racially and ethnically diverse population of injection drug users? Chassler D; Lundgren L; Lonsdale J Am J Addict; 2006; 15(6):440-9. PubMed ID: 17182446 [TBL] [Abstract][Full Text] [Related]
3. Promoting abstinence from cocaine and heroin with a methadone dose increase and a novel contingency. Epstein DH; Schmittner J; Umbricht A; Schroeder JR; Moolchan ET; Preston KL Drug Alcohol Depend; 2009 Apr; 101(1-2):92-100. PubMed ID: 19101098 [TBL] [Abstract][Full Text] [Related]
4. Real-time electronic diary reports of cue exposure and mood in the hours before cocaine and heroin craving and use. Epstein DH; Willner-Reid J; Vahabzadeh M; Mezghanni M; Lin JL; Preston KL Arch Gen Psychiatry; 2009 Jan; 66(1):88-94. PubMed ID: 19124692 [TBL] [Abstract][Full Text] [Related]
5. Self-reported cravings for heroin and cocaine during maintenance treatment with slow-release oral morphine compared with methadone: a randomized, crossover clinical trial. Falcato L; Beck T; Reimer J; Verthein U J Clin Psychopharmacol; 2015 Apr; 35(2):150-7. PubMed ID: 25679130 [TBL] [Abstract][Full Text] [Related]
6. Six-month trial of bupropion with contingency management for cocaine dependence in a methadone-maintained population. Poling J; Oliveto A; Petry N; Sofuoglu M; Gonsai K; Gonzalez G; Martell B; Kosten TR Arch Gen Psychiatry; 2006 Feb; 63(2):219-28. PubMed ID: 16461866 [TBL] [Abstract][Full Text] [Related]
8. Patterns and predictors of cocaine and crack use by clients in standard and enhanced methadone maintenance treatment. Grella CE; Anglin MD; Wugalter SE Am J Drug Alcohol Abuse; 1997 Feb; 23(1):15-42. PubMed ID: 9048145 [TBL] [Abstract][Full Text] [Related]
9. Injection and non-injection drug use and infectious disease in Baltimore City: differences by race. Keen L; Khan M; Clifford L; Harrell PT; Latimer WW Addict Behav; 2014 Sep; 39(9):1325-8. PubMed ID: 24837755 [TBL] [Abstract][Full Text] [Related]
10. Ethnic differences in HIV risk behaviors among methadone-maintained women receiving contingency management for cocaine use disorders. Barry D; Weinstock J; Petry NM Drug Alcohol Depend; 2008 Nov; 98(1-2):144-53. PubMed ID: 18684571 [TBL] [Abstract][Full Text] [Related]
11. Randomized trial of standard methadone treatment compared to initiating methadone without counseling: 12-month findings. Schwartz RP; Kelly SM; O'Grady KE; Gandhi D; Jaffe JH Addiction; 2012 May; 107(5):943-52. PubMed ID: 22029398 [TBL] [Abstract][Full Text] [Related]
12. Cocaine and crack use and HIV risk behaviors among high-risk methadone maintenance clients. Grella CE; Anglin MD; Wugalter SE Drug Alcohol Depend; 1995 Jan; 37(1):15-21. PubMed ID: 7882869 [TBL] [Abstract][Full Text] [Related]
13. Benefits of retention in methadone maintenance and chronic medical conditions as risk factors for premature death among older heroin addicts. Fareed A; Casarella J; Amar R; Vayalapalli S; Drexler K J Psychiatr Pract; 2009 May; 15(3):227-34. PubMed ID: 19461397 [TBL] [Abstract][Full Text] [Related]
14. Ethnic differences in substance abuse treatment retention, compliance, and outcome from two clinical trials. Milligan CO; Nich C; Carroll KM Psychiatr Serv; 2004 Feb; 55(2):167-73. PubMed ID: 14762242 [TBL] [Abstract][Full Text] [Related]
15. Drug use, health and social outcomes of hard-to-treat heroin addicts receiving supervised injectable opiate treatment: secondary outcomes from the Randomized Injectable Opioid Treatment Trial (RIOTT). Metrebian N; Groshkova T; Hellier J; Charles V; Martin A; Forzisi L; Lintzeris N; Zador D; Williams H; Carnwath T; Mayet S; Strang J Addiction; 2015 Mar; 110(3):479-90. PubMed ID: 25251885 [TBL] [Abstract][Full Text] [Related]
16. Examining racial/ethnic disparities in sexually transmitted diseases among recent heroin-using and cocaine-using women. Cavanaugh CE; Floyd LJ; Penniman TV; Hulbert A; Gaydos C; Latimer WW J Womens Health (Larchmt); 2011 Feb; 20(2):197-205. PubMed ID: 21314446 [TBL] [Abstract][Full Text] [Related]
17. Randomized trial of prize-based reinforcement density for simultaneous abstinence from cocaine and heroin. Ghitza UE; Epstein DH; Schmittner J; Vahabzadeh M; Lin JL; Preston KL J Consult Clin Psychol; 2007 Oct; 75(5):765-74. PubMed ID: 17907858 [TBL] [Abstract][Full Text] [Related]
18. Nonreporting of cannabis use: Predictors and relationship to treatment outcome in methadone maintained patients. Ghitza UE; Epstein DH; Preston KL Addict Behav; 2007 May; 32(5):938-49. PubMed ID: 16887281 [TBL] [Abstract][Full Text] [Related]
19. Agonist-like or antagonist-like treatment for cocaine dependence with methadone for heroin dependence: two double-blind randomized clinical trials. Grabowski J; Rhoades H; Stotts A; Cowan K; Kopecky C; Dougherty A; Moeller FG; Hassan S; Schmitz J Neuropsychopharmacology; 2004 May; 29(5):969-81. PubMed ID: 15039761 [TBL] [Abstract][Full Text] [Related]
20. Methadone maintenance treatment: a protective factor for cocaine injection in a street-recruited cohort of heroin users. Bravo MJ; Llorens N; Barrio G; Brugal MT; Santos S; Sordo L; de la Fuente L; Drug Alcohol Depend; 2010 Nov; 112(1-2):62-8. PubMed ID: 20591582 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]